Outcome for patients with metastatic (M2–3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy

This publication has 16 references indexed in Scilit:

• Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Results of a Randomized Study of Preradiation Chemotherapy Versus Radiotherapy Alone for Nonmetastatic Medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children’s Cancer Study Group PNET-3 Study
  Journal of Clinical Oncology, 2003
• Radiotherapy for medulloblastoma in children: A perspective on current international clinical research efforts
  Medical and Pediatric Oncology, 2002
• Outcome for children with high stage medulloblastoma: Results of the pediatric oncology group 9031
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Medulloblastoma: time–dose relationship based on a 30-year review
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International society of paediatric oncology (SIOP) and the (German) society of paediatric oncology (GPO): SIOP II
  Medical and Pediatric Oncology, 1995
• Preirradiation chemotherapy including “eight drugs in 1 day” regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study
  Journal of Neurosurgery, 1995
• Carboplatin and VP 16 in medulloblastoma: A phase II study of the French Society of Pediatric Oncology (sfop)
  Medical and Pediatric Oncology, 1994
• Kinetic considerations in the choice of treatment schedules for neuraxis radiotherapy
  The British Journal of Radiology, 1993
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958